1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zhou, M.-M. Huang, B. Olejniczak, E.T. Meadows, R.P. Shuker, S.B. Miyazaki, M. Trub, T. Shoelson, S.E. Feisk, S.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H12 N O6 P 261.168 n O-PHOSPHOTYROSINE PHOSPHONOTYROSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 3 388 393 10.1038/nsb0496-388 8599766 Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. 1996 US J.Biol.Chem. JBCHA3 0071 0021-9258 270 27407 Ptb Domains of Irs-1 and Shc Have Distinct But Overlapping Binding Specificities 1995 UK Nature NATUAS 0006 0028-0836 378 584 Structure and Ligand Recognition of the Phosphotyrosine Binding Domain of Shc 1995 US Mol.Cell.Biol. MCEBD4 2044 0270-7306 14 6433 Characterization of an Interaction between Insulin Receptor Substrate 1 and the Insulin Receptor by Using the Two-Hybrid System 1994 10.2210/pdb1irs/pdb pdb_00001irs 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12648.737 IRS-1 PTB DOMAIN 1 man polymer 1241.311 IL-4 RECEPTOR PHOSPHOPEPTIDE 1 man polymer INSULIN RECEPTOR SUBSTRATE 1 no no MGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGE FWMQVDDSVVAQNMHETILEAMRAMSDEFRPR MGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGE FWMQVDDSVVAQNMHETILEAMRAMSDEFRPR A polypeptide(L) no yes LVIAGNPA(PTR)RS LVIAGNPAYRS B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo BL21 (DE2) PLYSS Escherichia sample BL21 PTB DOMAIN OF IRS-1 9606 SKELETAL Homo sapiens PTB DOMAIN OF IRS-1 562 Escherichia coli PET30B human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-05-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_ref_seq_dif.details Y BNL 1996-03-22 REL 1 SET OF IDEAL BOND LENGTHS AND ANGLES USED DURING REFINEMENT: PARALLHDG.PRO IN X-PLOR. BRUNGER refinement X-PLOR MET 156 n 1 MET 156 A GLY 157 n 2 GLY 157 A PRO 158 n 3 PRO 158 A ALA 159 n 4 ALA 159 A PHE 160 n 5 PHE 160 A LYS 161 n 6 LYS 161 A GLU 162 n 7 GLU 162 A VAL 163 n 8 VAL 163 A TRP 164 n 9 TRP 164 A GLN 165 n 10 GLN 165 A VAL 166 n 11 VAL 166 A ILE 167 n 12 ILE 167 A LEU 168 n 13 LEU 168 A LYS 169 n 14 LYS 169 A PRO 170 n 15 PRO 170 A LYS 171 n 16 LYS 171 A GLY 172 n 17 GLY 172 A LEU 173 n 18 LEU 173 A GLY 174 n 19 GLY 174 A GLN 175 n 20 GLN 175 A THR 176 n 21 THR 176 A LYS 177 n 22 LYS 177 A ASN 178 n 23 ASN 178 A LEU 179 n 24 LEU 179 A ILE 180 n 25 ILE 180 A GLY 181 n 26 GLY 181 A ILE 182 n 27 ILE 182 A TYR 183 n 28 TYR 183 A ARG 184 n 29 ARG 184 A LEU 185 n 30 LEU 185 A CYS 186 n 31 CYS 186 A LEU 187 n 32 LEU 187 A THR 188 n 33 THR 188 A SER 189 n 34 SER 189 A LYS 190 n 35 LYS 190 A THR 191 n 36 THR 191 A ILE 192 n 37 ILE 192 A SER 193 n 38 SER 193 A PHE 194 n 39 PHE 194 A VAL 195 n 40 VAL 195 A LYS 196 n 41 LYS 196 A LEU 197 n 42 LEU 197 A ASN 198 n 43 ASN 198 A SER 199 n 44 SER 199 A GLU 200 n 45 GLU 200 A ALA 201 n 46 ALA 201 A ALA 202 n 47 ALA 202 A ALA 203 n 48 ALA 203 A VAL 204 n 49 VAL 204 A VAL 205 n 50 VAL 205 A LEU 206 n 51 LEU 206 A GLN 207 n 52 GLN 207 A LEU 208 n 53 LEU 208 A MET 209 n 54 MET 209 A ASN 210 n 55 ASN 210 A ILE 211 n 56 ILE 211 A ARG 212 n 57 ARG 212 A ARG 213 n 58 ARG 213 A CYS 214 n 59 CYS 214 A GLY 215 n 60 GLY 215 A HIS 216 n 61 HIS 216 A SER 217 n 62 SER 217 A GLU 218 n 63 GLU 218 A ASN 219 n 64 ASN 219 A PHE 220 n 65 PHE 220 A PHE 221 n 66 PHE 221 A PHE 222 n 67 PHE 222 A ILE 223 n 68 ILE 223 A GLU 224 n 69 GLU 224 A VAL 225 n 70 VAL 225 A GLY 226 n 71 GLY 226 A ARG 227 n 72 ARG 227 A SER 228 n 73 SER 228 A ALA 229 n 74 ALA 229 A VAL 230 n 75 VAL 230 A THR 231 n 76 THR 231 A GLY 232 n 77 GLY 232 A PRO 233 n 78 PRO 233 A GLY 234 n 79 GLY 234 A GLU 235 n 80 GLU 235 A PHE 236 n 81 PHE 236 A TRP 237 n 82 TRP 237 A MET 238 n 83 MET 238 A GLN 239 n 84 GLN 239 A VAL 240 n 85 VAL 240 A ASP 241 n 86 ASP 241 A ASP 242 n 87 ASP 242 A SER 243 n 88 SER 243 A VAL 244 n 89 VAL 244 A VAL 245 n 90 VAL 245 A ALA 246 n 91 ALA 246 A GLN 247 n 92 GLN 247 A ASN 248 n 93 ASN 248 A MET 249 n 94 MET 249 A HIS 250 n 95 HIS 250 A GLU 251 n 96 GLU 251 A THR 252 n 97 THR 252 A ILE 253 n 98 ILE 253 A LEU 254 n 99 LEU 254 A GLU 255 n 100 GLU 255 A ALA 256 n 101 ALA 256 A MET 257 n 102 MET 257 A ARG 258 n 103 ARG 258 A ALA 259 n 104 ALA 259 A MET 260 n 105 MET 260 A SER 261 n 106 SER 261 A ASP 262 n 107 ASP 262 A GLU 263 n 108 GLU 263 A PHE 264 n 109 PHE 264 A ARG 265 n 110 ARG 265 A PRO 266 n 111 PRO 266 A ARG 267 n 112 ARG 267 A LEU 489 n 1 LEU 489 B VAL 490 n 2 VAL 490 B ILE 491 n 3 ILE 491 B ALA 492 n 4 ALA 492 B GLY 493 n 5 GLY 493 B ASN 494 n 6 ASN 494 B PRO 495 n 7 PRO 495 B ALA 496 n 8 ALA 496 B PTR 497 n 9 PTR 497 B ARG 498 n 10 ARG 498 B SER 499 n 11 SER 499 B author_defined_assembly 2 dimeric B PTR 497 O-PHOSPHOTYROSINE B PTR 9 TYR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O GLU 162 A O GLU 7 A N LEU 187 A N LEU 32 A O ARG 184 A O ARG 29 A N VAL 195 A N VAL 40 A O ILE 192 A O ILE 37 A N LEU 206 A N LEU 51 A O GLY 234 A O GLY 79 A N VAL 225 A N VAL 70 A O PHE 220 A O PHE 65 A N SER 217 A N SER 62 1 A ARG 184 0.217 SIDE CHAIN 1 A ARG 212 0.203 SIDE CHAIN 1 A ARG 213 0.176 SIDE CHAIN 1 A ARG 227 0.312 SIDE CHAIN 1 A ARG 258 0.292 SIDE CHAIN 1 A ARG 265 0.238 SIDE CHAIN 1 A ARG 267 0.258 SIDE CHAIN 1 B ARG 498 0.310 SIDE CHAIN 1 A PRO 158 -83.94 47.10 1 A LEU 168 -45.06 157.63 1 A GLN 175 -150.05 -45.21 1 A THR 188 -99.16 46.08 1 A SER 189 38.61 28.74 1 A LYS 190 169.35 -34.83 1 A ASN 198 -99.52 37.11 1 A GLU 200 -133.27 -54.78 1 A SER 217 -64.14 90.35 1 A GLU 218 64.01 -88.53 1 A VAL 240 -107.86 -163.93 1 A ASP 242 -171.81 -146.93 1 A PHE 264 -81.13 -70.49 1 A ARG 265 171.37 145.98 1 A PRO 266 -55.68 -152.33 1 B ARG 498 72.84 -81.78 model building X-PLOR refinement X-PLOR phasing X-PLOR IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE 1 N N 2 N N A LEU 173 A LEU 18 HELX_P A THR 176 A THR 21 1 1 4 A VAL 245 A VAL 90 HELX_P A ASP 262 A ASP 107 1 2 18 B PRO 495 B PRO 7 HELX_P B PTR 497 B PTR 9 5 3 3 covale 1.309 both B ALA 496 B C ALA 8 1_555 B PTR 497 B N PTR 9 1_555 covale 1.309 both B PTR 497 B C PTR 9 1_555 B ARG 498 B N ARG 10 1_555 COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE) PHOSPHOTYROSINE BINDING DOMAIN (PTB), COMPLEX, SIGNAL TRANSDUCTION, COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE), COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE) complex IRS1_HUMAN UNP 1 1 P35568 MASPPESDGFSDVRKVGYLRKPKSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESCFNINKRADSKN KHLVALYTRDEHFAIAADSEAEQDSWYQALLQLHNRAKGHHDGAAALGAGGGGGSCSGSSGLGEAGEDLSYGDVPPGPAF KEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGEFWMQV DDSVVAQNMHETILEAMRAMSDEFRPRSKSQSSSNCSNPISVPLRRHHLNNPPPSQVGLTRRSRTESITATSPASMVGGK PGSFRVRASSDGEGTMSRPASVDGSPVSPSTNRTHAHRHRGSARLHPPLNHSRSIPMPASRCSPSATSPVSLSSSSTSGH GSTSDCLFPRRSSASVSGSPSDGGFISSDEYGSSPCDFRSSFRSVTPDSLGHTPPARGEEELSNYICMGGKGPSTLTAPN GHYILSRGGNGHRCTPGTGLGTSPALAGDEAASAADLDNRFRKRTHSAGTSPTITHQKTPSQSSVASIEEYTEMMPAYPP GGGSGGRLPGHRHSAFVPTRSYPEEGLEMHPLERRGGHHRPDSSTLHTDDGYMPMSPGVAPVPSGRKGSGDYMPMSPKSV SAPQQIINPIRRHPQRVDPNGYMMMSPSGGCSPDIGGGPSSSSSSSNAVPSGTSYGKLWTNGVGGHHSHVLPHPKPPVES SGGKLLPCTGDYMNMSPVGDSNTSSPSDCYYGPEDPQHKPVLSYYSLPRSFKHTQRPGEPEEGARHQHLRLSTSSGRLLY AATADDSSSSTSSDSLGGGYCGARLEPSLPHPHHQVLQPHLPRKVDTAAQTNSRLARPTRLSLGDPKASTLPRAREQQQQ QQPLLHPPEPKSPGEYVNIEFGSDQSGYLSGPVAFHSSPSVRCPSQLQPAPREEETGTEEYMKMDLGPGRRAAWQESTGV EMGRLGPAPPGAASICRPTRAVPSSRGDYMTMQMSCPRQSYVDTSPAAPVSYADMRTGIAAEEVSLPRATMAAASSSSAA SASPTGPQGAAELAAHSSLLGGPQGPGGMSAFTRVNLSPNRNQSAKVIRADPQGCRRRHSSETFSSTPSATRVGNTVPFG AGAAVGGGGGSSSSSEDVKRHSSASFENVWLRPGELGGAPKEPAKLCGAAGGLENGLNYIDLDLVKDFKQCPQECTPEPQ PPPPPPPHQPLGSGESSSTRRSSEDLSAYASISFQKQPEDRQ IL4RA_HUMAN UNP 2 1 P24394 MGWLCSGLLFPVSCLVLLQVASSGNMKVLQEPTCVSDYMSISTCEWKMNGPTNCSTELRLLYQLVFLLSEAHTCIPENNG GAGCVCHLLMDDVVSADNYTLDLWAGQQLLWKGSFKPSEHVKPRAPGNLTVHTNVSDTLLLTWSNPYPPDNYLYNHLTYA VNIWSENDPADFRIYNVTYLEPSLRIAASTLKSGISYRARVRAWAQCYNTTWSEWSPSTKWHNSYREPFEQHLLLGVSVS CIVILAVCLLCYVSITKIKKEWWDQIPNPARSRLVAIIIQDAQGSQWEKRSRGQEPAKCPHWKNCLTKLLPCFLEHNMKR DEDPHKAAKEMPFQGSGKSAWCPVEISKTVLWPESISVVRCVELFEAPVECEEEEEVEEEKGSFCASPESSRDDFQEGRE GIVARLTESLFLDLLGEENGGFCQQDMGESCLLPPSGSTSAHMPWDEFPSAGPKEAPPWGKEQPLHLEPSPPASPTQSPD NLTCTETPLVIAGNPAYRSFSNSLSQSPCPRELGPDPLLARHLEEVEPEMPCVPQLSEPTTVPQPEPETWEQILRRNVLQ HGAAAAPVSAPTSGYQEFVHAVEQGGTQASAVVGLGPPGEAGYKAFSSLLASSAVSPEKCGFGASSGEEGYKPFQDLIPG CPGDPAPVPVPLFTFGLDREPPRSPQSSHLPSSSPEHLGLEPGEKVEDMPKPPLPQEQATDPLVDSLGSGIVYSALTCHL CGHLKQCHGQEDGGQTPVMASPCCGCCCGDRSSPPTTPLRAPDPSPGGVPLEASLCPASLAPSGISEKSKSSSSFHPAPG NAQSSSQTPKIVNFVSVGPTYMRVS 157 267 1IRS 157 267 P35568 A 1 2 112 489 499 1IRS 489 499 P24394 B 2 1 11 2 TYR modified residue PTR 497 1IRS B P24394 UNP 497 9 4 3 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 162 A GLU 7 A ILE 167 A ILE 12 A ILE 182 A ILE 27 A THR 188 A THR 33 A THR 191 A THR 36 A LYS 196 A LYS 41 A VAL 204 A VAL 49 A GLN 207 A GLN 52 A GLY 234 A GLY 79 A PHE 236 A PHE 81 A PHE 220 A PHE 65 A VAL 225 A VAL 70 A ILE 211 A ILE 56 A SER 217 A SER 62 1 P 1